Post Oak Pharmaceuticals is an early stage development company focused on developing repurposed drug combinations that target cancer indications representing potentially billions of dollars of worldwide markets. As of 2014, Post Oak was also developing a bioadhesive patch to treat ulcerations occurring in the mouth.